Showing results (491-500 of 963) with videos related to

Sort By:
Pageof 97
Molecular & General Genetics : MGG|November 1, 1991
Analysis of interferon-gamma resistant mutants that are possibly defective in their signaling mechanismG S Feng, W Dai, S L Gupta, et al.
Shock (Augusta, Ga.)|November 9, 2001
Perioperative treatment with human recombinant interferon-gamma: a randomized double-blind clinical trialC Schinkel, K Licht, S Zedler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 9, 2001
Antifungal activity against Candida species of the selective serotonin-reuptake inhibitor, sertralineC Lass-Flörl, M P Dierich, D Fuchs, et al.
Clinical Chemistry|November 2, 1999
Neopterin is an independent prognostic variable in females with breast cancerC Murr, A Bergant, M Widschwendter, et al.
Pharmacological Research|August 5, 2009
Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markersK Kurz, T Teerlink, M Sarcletti, et al.
Clinical and Experimental Immunology|February 4, 2003
Atorvastatin suppresses interferon-gamma -induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell linesG Neurauter, B Wirleitner, A Laich, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
CMV infections in bone marrow transplanted patients--evaluation of prophylaxis with Cytotect (CMV hyperimmuneglobulin)F Zintl, I Färber, J Hermann, et al.
Amino Acids|December 29, 2007
Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrationsM Ploder, G Neurauter, A Spittler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 17, 2011
Lessons drawn from recent HIV vaccine efficacy trialsJonathan D Fuchs, Magda E Sobieszczyk, Scott M Hammer, et al.
European Journal of Clinical Pharmacology|August 19, 2007
Adverse events of blood-pressure-lowering drugs: evidence of high incidence in a clinical settingCarla B C Gonçalves, Leila B Moreira, Miguel Gus, et al.
Pageof 97